PF-Atlas › Clinical Trials › NCT05187715
To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.
Simvastatin 40mg · Not specified
Registry ID
NCT05187715
Phase
Not specified
Status
Unknown
Drug / intervention
Simvastatin 40mg
Sponsor
Institute of Liver and Biliary Sciences, India
Start
2022-02-26
About this trial
Simvastatin 40mg is evaluated in NCT05187715, a idiopathic pulmonary fibrosis study sponsored by Institute of Liver and Biliary Sciences, India. Current status: Unknown.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05187715 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.